# Enteroaggregative E.Coli (EAEC)

> **NCT00362869** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 5 (actual)

## Conditions studied

- Escherichia Coli Infections

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Placebo
- **BIOLOGICAL:** Enteroaggregative E. coli (EAEC)

## Key facts

- **NCT ID:** NCT00362869
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2008-08
- **Final completion:** 2008-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362869, "Enteroaggregative E.Coli (EAEC)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00362869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*